These findings suggest that when Ad-MSCs and PBMCs are combined, more complex interactions occur, notably affecting the expression profiles of interleukins 8 and 12, potentially due to critical changes within the tumor secretome. The gene discussed is CXCL8; the disease is neoplasm.